M02.89 ICD-10-CM Code: Other reactive arthropathies, multiple sites
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the musculoskeletal system and connective tissue (M00-M99) / Infectious arthropathies (M00-M02)
M02.89
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceOther reactive arthropathies, multiple sites
Joint inflammation affecting multiple different sites in the body that develops as a reaction to an infection or other trigger.

Buddy Insight
This diagnosis represents reactive arthropathy affecting multiple joint sites simultaneously, indicating widespread inflammation secondary to a remote infectious trigger.
CMS-HCC V28
MappedHCC 92
RAF 0.479
CMS-HCC V24
MappedHCC 39
RAF 0.401
ACA/HHS
MappedHCC 55
Varies by metal level
ESRD/PACE
MappedHCC 39
RAF 0.092
RXHCC
N/A—
Not mapped
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for M02.89 in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for M02.89 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for M02.89 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for M02.89 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for M02.89 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for M02.89 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for M02.89 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is M02.89 an HCC code?
Yes. M02.89 (Other reactive arthropathies, multiple sites) maps to Bone/Joint/Muscle/Severe Soft Tissue Infections/Necrosis under the CMS-HCC V28 risk adjustment model (and Bone/Joint/Muscle Infections/Necrosis under V24), with a community non-dual aged RAF of 0.479. It is billable for payment year 2026.
Coder answer: M02.89 is billable and maps to V28 HCC 92, Bone/Joint/Muscle/Severe Soft Tissue Infections/Necrosis. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- M02.89
- Description
- Other reactive arthropathies, multiple sites
- HCC (V28)
- HCC 92 — Bone/Joint/Muscle/Severe Soft Tissue Infections/Necrosis
- RAF
- 0.479
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work M02.89 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for M02.89
For M02.89 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed M02.89 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
M02.89 is the ICD-10-CM diagnosis code for other reactive arthropathies, multiple sites. Joint inflammation affecting multiple different sites in the body that develops as a reaction to an infection or other trigger. M02.89 sits in the ICD-10-CM chapter for diseases of the musculoskeletal system and connective tissue (m00-m99), within the section covering infectious arthropathies (m00-m02).
Under the CMS-HCC V28 risk adjustment model, M02.89 maps to Bone/Joint/Muscle/Severe Soft Tissue Infections/Necrosis (HCC 92) with a community, non-dual, aged base RAF weight of 0.479. Under the older CMS-HCC V24 model, M02.89 maps to Bone/Joint/Muscle Infections/Necrosis (HCC 39) with a community, non-dual, aged base RAF weight of 0.401. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Use this code when reactive arthropathy involves three or more different joint sites; list specific affected sites in documentation. Because M02.89 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for M02.89 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Use this code when reactive arthropathy involves three or more different joint sites; list specific affected sites in documentation
- •Consider coding individual site-specific codes if only one or two sites are involved, as those are more precise
Clinical Significance
This diagnosis represents reactive arthropathy affecting multiple joint sites simultaneously, indicating widespread inflammation secondary to a remote infectious trigger. Multiple joint involvement suggests a more systemic process with greater functional impact and complexity, requiring comprehensive management and monitoring.
Documentation Requirements
- ✓Clinical evidence of inflammation in multiple joint sites
- ✓Documentation of reactive nature - inflammation secondary to remote infection
- ✓Identification of at least two different anatomical joint sites affected
- ✓Evidence ruling out direct septic arthritis at multiple sites
- ✓Documentation of triggering infection or infectious process (if identified)
- ✓Physical examination findings consistent with polyarthritis
- ✓Exclusion of other systemic arthropathies (rheumatoid arthritis, lupus)
- ✓Assessment of overall functional impact and disability
Commonly Confused Codes
- •M06.9: Rheumatoid arthritis, unspecified (autoimmune vs reactive polyarthritis)
- •M79.3: Panniculitis, unspecified (soft tissue vs joint inflammation)
- •M35.9: Systemic involvement of connective tissue, unspecified (autoimmune vs reactive)
- •Individual site-specific reactive arthropathy codes (when only one site documented)
- •M25.50: Pain in unspecified joint (symptom vs specific arthropathy diagnosis)

